Wegovy logo PNG: reading the branding behind a licensed weight-loss medicine

Wegovy is a brand of semaglutide made by Novo Nordisk; its logo appears on UK-licensed pre-filled injection pens and, as of June 2026, on the first oral GLP-1 weight-loss tablet approved in the UK.
A logo can be copied or printed onto a fake pen — the MHRA has seized counterfeit weight-loss pens bearing convincing branding, including some that contained insulin rather than semaglutide.
The only way to confirm a Wegovy product is legitimate is to obtain it through a pharmacy you can verify on the GPhC register at pharmacyregulation.org.
Wegovy is a prescription-only medicine; a GPhC-registered prescriber must assess your suitability before it can be legally supplied.

If you have searched for the Wegovy logo or a PNG of it, you are most likely trying to verify that the product in front of you is genuine, or you want to understand what the Wegovy brand actually represents. Wegovy is the brand name Novo Nordisk uses for semaglutide 2.4mg (and, from January 2026, the higher 7.2mg dose), a prescription-only medicine licensed in the UK for weight management in eligible adults. It is not a consumer product you can purchase freely, and no logo, however authentic-looking, confirms that a pen is the real thing. Only the supply chain it came from does that.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to use Wegovy's branding as a safety check, not a shortcut

Step 1: understand what the Wegovy brand actually covers

The Wegovy name and its distinctive logo belong to Novo Nordisk, the Danish pharmaceutical company that developed semaglutide. In the UK, the Wegovy brand covers two licensed presentations for weight management: the once-weekly subcutaneous injection pen (available in doses from 0.25mg up to the 7.2mg maintenance dose approved in January 2026) and, from 11 June 2026, the Wegovy tablet, the first oral GLP-1 medicine licensed in the UK for weight management. The injection and the tablet carry different branded packaging, different dosing schedules and different instructions for use.

The injection pens follow a titration path beginning at 0.25mg, with the prescriber guiding increases roughly every four weeks up to the maintenance dose. The tablet starts at 1.5mg and escalates through 4mg and 9mg to a 25mg maintenance dose. These are clinical details your prescriber works through with you; they are not choices you make by reading a logo. The NHS semaglutide medicines page has a clear patient-level summary of both forms if you want a reliable starting point.

Knowing the brand exists in two distinct forms matters if you are comparing boxes or looking up images, because the packaging and logo treatment differs notably between the pen and the tablet versions. Neither version looks identical to Ozempic, which is also semaglutide but licensed solely for type 2 diabetes, not weight loss. If you want a broader picture of how semaglutide fits into weight management, our semaglutide overview covers the distinction clearly.

Step 2: recognise what a logo cannot tell you

This is the part that matters most. The MHRA has warned repeatedly that counterfeit weight-loss pens circulate online, including through social media sellers, with packaging and logos that closely mimic the genuine article. In October 2025, enforcement teams raided the first UK site producing fake tirzepatide pens; across 2025, roughly 20 million doses of illegally traded weight-loss medicines (around £45m street value) were seized. Some fake pens seized in earlier operations contained insulin rather than semaglutide, which poses serious medical risk.

If you are researching what genuine Wegovy packaging looks like, a Wegovy PNG showing the authentic branding can help you understand what to expect, but it cannot tell you whether the pen in a seller's photo is real. Counterfeiters are not deterred by logo complexity. The safety check is not the label; it is the pharmacy. Any UK pharmacy dispensing prescription medicines must be registered with the General Pharmaceutical Council, and you can verify that registration at the GPhC's pharmacy register in under a minute.

Red flags worth knowing: offers of Wegovy without a prescription or clinical assessment, prices dramatically below typical private market rates, and discount codes from sellers you cannot verify. The guide to where Wegovy can be bought legally in the UK covers this in full.

Step 3: verify the pharmacy, not just the packaging

Once you know the genuine Wegovy branding exists in two forms, and that branding alone is not a safety guarantee, the practical question becomes: how do you find a legitimate source? In the UK, Wegovy is a prescription-only medicine. That means a qualified prescriber must assess whether it is appropriate for you before any supply can happen. Eligibility under the licensed indication covers adults with a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as hypertension or high cholesterol. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. The prescriber also checks your medical history, current medicines and contraindications; the logo on the box is the last thing that matters in that process.

On the NHS, Wegovy is available through specialist weight management services under NICE guidance TA875, though waiting lists are commonly long and eligibility criteria are strict. Many people access it privately through a GPhC-registered online pharmacy. Before ordering your next prescription anywhere, it is worth spending a few minutes on a Tuesday afternoon (or whenever it suits you) running the pharmacy's registration number through the GPhC's online register. Ours is 9012878, verifiable directly at pharmacyregulation.org. Our about page explains how our pharmacy and clinical team are structured if that helps too.

The full Wegovy treatment page covers the medicine in detail, including how our prescribers review consultations and what the process looks like from start to delivery. If you are early in thinking about whether Wegovy might be right for you, the eligibility guide is a good next read. For a broader look at the treatment options available through nume, the weight-loss treatments overview gives a clear side-by-side picture. Our clinical team, led by our clinical director, reviews every consultation personally.

If you have questions the pages do not answer, our team is available through the contact page seven days a week. When you are ready to find out whether you are eligible, check your eligibility through a free consultation — there is no obligation, and the clinical review happens the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions